We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.02B
AUM Growth
-$31.8M
Cap. Flow
-$14.7M
Cap. Flow %
-0.37%
Top 10 Hldgs %
55.91%
Holding
627
New
130
Increased
130
Reduced
70
Closed
208
Avg Time Held Equity + Options
3.7 quarters
Top 10 Avg Time Held Equity + Options
1.3 quarters
Top 20 Avg Time Held Equity + Options
1.5 quarters
Avg Time Held Equity only
3.8 quarters
Top 10 Avg Time Held Equity only
1.3 quarters
Top 20 Avg Time Held Equity only
1.5 quarters

Top Buys

Rank Stock Value
1
DFS icon
Discover Financial Services
DFS
+$191M
2
SMAR icon
Smartsheet Inc.
SMAR
+$188M
3
FYBR icon
Frontier Communications
FYBR
+$124M
4
SUM icon
Summit Materials, Inc. Class A Common Stock
SUM
+$95M
5
ALTR icon
Altair Engineering Inc
ALTR
+$92.6M

Top Sells

Rank Stock Value
1
CTLT icon
CATALENT, INC.
CTLT
+$234M
2
MRO icon
Marathon Oil Corporation
MRO
+$222M
3
SRCL icon
Stericycle Inc
SRCL
+$172M
4
AXNX icon
Axonics, Inc. Common Stock
AXNX
+$150M
5
PRFT icon
Perficient Inc
PRFT
+$79.6M

Sector Composition

Rank Sector Weight
1 Technology 28.76%
2 Energy 15.79%
3 Communication Services 7.77%
4 Consumer Staples 7.72%
5 Financials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
DECK icon
151
Deckers Outdoor
DECK
$11.3B
$2.03M 0.05%
10,000
-2,000
-17% -$362K
2024 Q2
2 quarters
LCID icon
152
PUT
Lucid Motors
LCID
$1.49B
$2M 0.05%
157,500
– –
2023 Q2
6 quarters
LEGT
153
DELISTED
Legato Merger Corp III
LEGT
$1.99M 0.05%
+193,740
New +$1.99M
2024 Q4
0 quarters
KNSA icon
154
Kiniksa Pharmaceuticals
KNSA
$6.22B
$1.97M 0.05%
99,632
+24,463
+33% +$558K
2022 Q3
9 quarters
SN icon
155
SharkNinja
SN
$26.1B
$1.95M 0.05%
+20,000
New +$2.04M
2024 Q4
0 quarters
INVZ icon
156
Innoviz Technologies
INVZ
$91.8M
$1.93M 0.05%
+1,150,000
New +$950K
2024 Q4
0 quarters
IDYA icon
157
IDEAYA Biosciences
IDYA
$3.48B
$1.87M 0.05%
72,716
+24,112
+50% +$683K
2022 Q3
9 quarters
INSM icon
158
Insmed
INSM
$22B
$1.84M 0.05%
26,615
+4,796
+22% +$345K
2022 Q1
11 quarters
VISN icon
159
Vistance Networks Inc
VISN
$1.4B
$1.82M 0.05%
+350,000
New +$1.96M
2024 Q4
0 quarters
ATEC icon
160
Alphatec Holdings
ATEC
$1.65B
$1.82M 0.05%
197,992
+35,695
+22% +$285K
2023 Q4
4 quarters
KDK icon
161
Kodiak AI
KDK
$335M
$1.82M 0.05%
165,422
– –
2023 Q2
6 quarters
TJX icon
162
TJX Companies
TJX
$153B
$1.81M 0.05%
+15,000
New +$1.79M
2024 Q4
0 quarters
BMRN icon
163
BioMarin Pharmaceuticals
BMRN
$10.6B
$1.76M 0.04%
+26,840
New +$1.8M
2024 Q4
0 quarters
BPMC icon
164
DELISTED
Blueprint Medicines
BPMC
$1.76M 0.04%
20,133
-2,120
-10% -$194K
2022 Q4
8 quarters
ON icon
165
ON Semiconductor
ON
$30.2B
$1.73M 0.04%
27,500
+17,500
+175% +$1.21M
2023 Q1
7 quarters
IRTC icon
166
iRhythm Holdings
IRTC
$3.52B
$1.73M 0.04%
19,191
-5,535
-22% -$435K
2023 Q1
7 quarters
AAL icon
167
PUT
American Airlines Group
AAL
$8.45B
$1.7M 0.04%
10,645,000
+870,000
+9% +$12.5M
2020 Q1
19 quarters
OFIX icon
168
Orthofix Medical
OFIX
$374M
$1.7M 0.04%
97,461
+12,578
+15% +$219K
2023 Q1
7 quarters
ADI icon
169
Analog Devices
ADI
$197B
$1.7M 0.04%
8,000
+3,000
+60% +$663K
2024 Q2
2 quarters
EVLV icon
170
Evolv Technologies
EVLV
$821M
$1.7M 0.04%
430,223
– –
2021 Q3
13 quarters
ITCI icon
171
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.69M 0.04%
20,284
+2,941
+17% +$242K
2024 Q2
2 quarters
BBIO icon
172
BridgeBio Pharma
BBIO
$12.8B
$1.68M 0.04%
61,118
+2,522
+4% +$65.2K
2024 Q2
2 quarters
CDLX icon
173
Cardlytics
CDLX
$12.1M
$1.67M 0.04%
45,000
– –
2023 Q4
4 quarters
VALE icon
174
Vale
VALE
$58B
$1.66M 0.04%
+187,296
New +$1.91M
2024 Q4
0 quarters
ANNX icon
175
Annexon
ANNX
$762M
$1.64M 0.04%
318,884
-1,690
-0.5% -$10.4K
2022 Q1
11 quarters
5 6
7
8 9

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2024 Portfolio in Review

As of Q4 2024, UBS O'Connor held 627 positions worth $4.02B, down 0.79% from $4.05B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor's Q4 2024 filing shows 130 new, 130 increased, 70 reduced and 208 closed positions. Its largest new stake was Discover Financial Services: 1,166,698 shares worth $202M. The largest sale was CATALENT, INC., an estimated $234M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 20% a quarter earlier, followed by Energy and Communication Services.

  • UBS O'Connor's largest Q4 2024 buy was Discover Financial Services: 1,166,698 shares worth $202M.
  • UBS O'Connor added most to Smartsheet Inc. in Q4 2024, an estimated $188M increase.
  • UBS O'Connor's biggest Q4 2024 reduction was US Steel, cutting an estimated $62.2M.
  • UBS O'Connor fully exited CATALENT, INC. in Q4 2024, selling an estimated $234M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.02B portfolio in Q4 2024.
  • UBS O'Connor opened 130 new positions and closed 208 in Q4 2024.
  • UBS O'Connor's portfolio value fell 0.79% quarter-over-quarter to $4.02B.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.